20 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/not-game-changing-boehringers-phase-3-lung-data-get-muted-response-analysts
11 Feb 2025
// PRESS RELEASE
https://www.boehringer-ingelheim.com/human-health/lung-diseases/pulmonary-fibrosis/nerandomilast-primary-endpoint-phase-3-fibroneer-ild-pulmonary-fibrosis